Abeona Therapeutics ABEO 深 沪
交易中 08-19 10:30:17 美东时间
6.17
+0.010
+0.16%
华盛通- 最 高6.32
- 今 开6.31
- 成交量 12.70万股
- 最 低 6.17
- 昨 收 6.16
- 总市值 3.53亿
- 52周最高 7.65
- 市盈率 静 6.08
- 换手率 0.22%
- 52周最低 4.00
- 委 比 40.00%
- 总股本 5718.40万
- 历史最高 750.00
- 量 比 0.34
- 振 幅 2.44%
- 历史最低 2.19
- 每 手 1
- 风险率 0.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
Oppenheimer Maintains Outperform on Abeona Therapeutics, Lowers Price Target to $21
Oppenheimer analyst Jeff Jones maintains Abeona Therapeutics (NASDAQ:ABEO) with a Outperform and lowers the price target from $22 to $21.
08-15 01:00
Abeona Therapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.
Abeona Therapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.
08-13 19:59
Abeona Therapeutics Activates Cincinnati Children’s As Seventh Qualified Treatment Center For Administration Of ZEVASKYN To Treat Wounds In Patients With Recessive Dystrophic Epidermolysis Bullosa
Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced the activation of Cincinnati Children’s as the seventh Qualified Treatment Center (QTC) for the administration of ZEVASKYN® (prademagene zami...
07-21 19:37
Abeona Therapeutics announces resignation of board member
Abeona Therapeutics ( ($ABEO) ) just unveiled an update. On June 11, 2026, Abeo...
06-12 20:01
Abeona Advances ABO-701 T-Cell Therapy Toward IND
Abeona Therapeutics ( ($ABEO) ) has shared an update. On June 3, 2026, Abeona T...
06-04 20:00
美股大行评级 | 瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
05-29 18:09
